NCT00927043
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Pamplona, Navarre, Spain
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
153 public trials
10 recruiting studies
Carcinoma, Renal Cell trial results
NCT00267748
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Hot Springs, Arkansas, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site Baldwin Park, California, United States
NCT00113529
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Ann Arbor, Michigan, United States
- Pfizer Investigational Site New York, United States
- Pfizer Investigational Site Philadelphia, Pennsylvania, United States
NCT01328691
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00077974
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Duarte, California, United States
- Pfizer Investigational Site Pasadena, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Boston, Massachusetts, United States
Completed
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar
NCT00895674
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Many Locations, Argentina
- Many Locations, Austria
- Many Locations, China
- Many Locations, Colombia
NCT01087060
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00254540
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Pfizer Investigational Site Akita, Japan
- Pfizer Investigational Site Sapporo, Hokkaido, Japan
- Pfizer Investigational Site Tsukuba, Ibaragi, Japan
- Pfizer Investigational Site Osaka, Japan
NCT00083889
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Jonesboro, Arkansas, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00089648
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Pfizer Investigational Site Duarte, California, United States
- Pfizer Investigational Site Pasadena, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site Chicago, Illinois, United States